Search the Newsreel

Motorcar Parts of America Inc (54M.MU) Analyst insights, Price targets and Recommendations

This article provides analyst insights, price targets, and recommendations for Motorcar Parts of America Inc (54M.MU), listed on Yahoo Finance. It details recent analyst actions, including upgrades, downgrades, and initiations of coverage from various firms. The stock was trading at 10.90 EUR with no …

Upgraded 2026 Revenue Outlook And Buybacks Might Change The Case For Investing In Corcept (CORT)

Corcept Therapeutics reported increased net income in Q2 2026 and raised its full-year 2026 revenue guidance to US$1.10–1.20 billion, along with completing a share repurchase program. This updated outlook, driven by confidence in its cortisol-modulation portfolio and new indications, signals a potential shift in …

Orchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Orchestra BioMed (NASDAQ:OBIO) reported a quarterly loss of $0.38 per share, missing analyst estimates by $0.03. Despite the earnings miss and negative financial metrics, the company's shares increased by 5.2% and insiders purchased a significant amount of stock. Analyst sentiment is mixed but generally …

American Public Education Plans AI Support From Enrollment to Careers

American Public Education, Inc. (APEI) is developing an AI-powered Student Lifecycle Platform (SLP) with Salesforce to transform the student experience across its American Public University System. This platform, utilizing Salesforce's next-generation SIS, Data 360, and Agentforce, aims to unify student services from admissions to …

Oracle, Quantinuum partner to bring quantum computing to cloud

Aug 11 (Reuters) - Quantinuum and Oracle on Tuesday announced a multi-year partnership aimed at bringing quantum computing ‌capabilities to Oracle's cloud platform, as technology firms ‌race to commercialize the nascent technology. Financial terms of the partnership and a ​deployment date were not disclosed. …

Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure

Quantinuum's most advanced quantum computer, Helios, will be deployed in a US-based OCI AI data center to enable hybrid quantum-AI workloads as an OCI service. Quantinuum and Oracle aim to support enterprise, AI lab, academic, and research applications spanning drug discovery, materials science, financial …

Motorcar Parts of America (MPAA): Donald Smith & Co. discloses 6.54% ownership stake

Donald Smith & Co., Inc. has disclosed a beneficial ownership of 1,237,941 shares, or 6.54%, of Motorcar Parts of America, Inc. (MPAA) common stock through a Schedule 13G SEC filing. The investment adviser holds significant sole voting and dispositive power over these shares, with …

Salesforce (CRM): Do Leadership Shifts Cloud Its Positioning in Sensitive Government AI Workloads?

In early August 2026, Salesforce announced that President and Chief Engineering and Customer Success Officer Srini Tallapragada had stepped down, moving into a one-year Special Advisor role to support product, technology, business development, and customer transitions while his existing equity awards continue to vest. …

Salesforce (CRM) Lost A $600,000 Contract To An In House AI CRM

Curative has replaced its Salesforce (NYSE:CRM) deployment with an in-house, AI-powered CRM, terminating a significant US$600,000 annual contract. This move highlights a potential shift in demand towards custom, AI-heavy platforms over traditional SaaS CRM offerings, raising questions about whether large enterprises will continue to …

Salesforce (CRM) Lost A Major Healthcare Customer To An In House AI CRM

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Curative ends a major Salesforce (NYSE:CRM) contract and rolls out its own in-house, AI-powered CRM platform for healthcare operations. The company cites cost and speed …

Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates

Orchestra Biomed Holdings (NASDAQ: OBIO) reported second-quarter EPS of $-0.380

Stifel reiterates Salesforce stock rating ahead of earnings

Stifel maintained its Buy rating and $250 price target for Salesforce (NYSE:CRM) stock, anticipating in-line to modest upside results for Q2 revenue and remaining performance obligations. The firm expects subscription and support growth of 10% and 13% respectively in constant currency. Salesforce shares are …

Salesforce to acquire Fin for $3.6bn

Salesforce has agreed to acquire AI customer service platform Fin for approximately $3.6 billion to enhance its automation and AI agent capabilities. The acquisition, expected to close in Q4 fiscal year 2027, will integrate Fin's technology with Salesforce's Agentforce platform, aiming to improve customer …

Oracle Adds New Fusion Agentic Applications and AI Agents to Help Organizations Improve Talent Management

Latest AI innovations in Oracle Fusion Cloud HCM help customers accelerate employee development, guide talent decisions, and respond faster to changing business needs AUSTIN, Texas, Aug. 11, 2026 /PRNewswire/ -- Oracle today announced new Oracle Fusion Agentic Applications and AI agents for HR to …

Oracle's AI Infrastructure Surge: Smart Growth Bet or a Costlier Trap?

Oracle Corporation ORCL is deepening its bet on AI-driven cloud infrastructure, expanding data center capacity across Texas, New Mexico, Wisconsin and Michigan while continuing large-scale funding commitments to support demand for GPU computing. In an August 2026 statement, the company reiterated its approach of …

Intellinum Achieves "Oracle Validated: Oracle Fusion Cloud Application Expertise" for Delivering Proven, Repeatable Integration

Intellinum FlexiPro Label offers customers a fully automated, event-driven barcode labeling and printing solution designed to work with Oracle Fusion Cloud SCM DALLAS, Aug. 11, 2026 /PRNewswire/ -- Intellinum, a leading provider of barcode labeling and mobility solutions, and an Oracle partner today announced …

Motorcar Parts earnings missed by $0.90, revenue fell short of estimates

Motorcar Parts (NASDAQ: MPAA) reported first-quarter EPS of $-0.71, missing analyst estimates by $0.90. Revenue for the quarter was $168.02M, falling short of the consensus estimate of $183.39M. Despite the earnings miss, the stock is up 19.77% in the last three months but down …

Exclusive: Curative Ditches $600,000 Salesforce Contract Says 'AI Changes the Economics of Building Software,' But CRM Warns of Security Risks

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Curative expanded its AI-built software strategy beyond CRM after dropping a roughly $600,000-a-year Salesforce, Inc. contract, saying internally developed systems cut administrative costs, while Salesforce warned that …

Orchasp consolidated net profit declines 48.15% in the June 2026 quarter

Motorcar Parts Posts $13.4M Loss; Order Timing Hit Sales

Motorcar Parts of America (MPAA) reported a net loss of $13.4 million, or $0.71 per share, for Q1 fiscal 2027, compared to a net income in the prior year, primarily due to the timing of customer orders and competitor bankruptcy inventory liquidations. Despite the …

Orchasp net profit falls 48% in Q1FY27 as revenue plunges

Corcept Therapeutics Incorporat (CORT) Stock Forecasts

Argus has raised its target price for Corcept Therapeutics Inc (CORT) to $115.00, noting the company's focus on developing medications for severe metabolic, oncologic, and neuropsychiatric disorders. The current price for CORT is $111.86. The report emphasizes the company's commercial-stage pharmaceutical operations.

Handelsbanken Fonder AB Sells 37,039 Shares of Salesforce Inc. $CRM

Handelsbanken Fonder AB has reduced its stake in Salesforce Inc. by 8.9%, selling 37,039 shares and now owning 377,259 shares valued at approximately $59.1 million. Salesforce reported strong quarterly earnings, beating analyst estimates, and pays a quarterly dividend. The company maintains a "Moderate Buy" …

What Salesforce is and why it matters in business software

Salesforce, founded in 1999, pioneered cloud-based software delivery and became the world's largest CRM vendor. It has evolved into a broad business platform, incorporating acquisitions like Slack and Tableau, and is now heavily focused on integrating artificial intelligence into its offerings under the "Agentforce" …

KMG Fiduciary Partners LLC Trims Stake in Salesforce Inc. $CRM

KMG Fiduciary Partners LLC significantly reduced its stake in Salesforce Inc. (NYSE:CRM) by 40.1% in the second quarter, selling 12,231 shares and retaining 18,239 shares valued at $2.86 million. Despite this, institutional investors collectively own 80.43% of Salesforce. The company recently reported strong quarterly …

E. Ohman J or Asset Management AB Grows Position in Salesforce Inc. $CRM

E. Ohman J or Asset Management AB increased its stake in Salesforce Inc. by 8.3% during the second quarter, bringing its total holdings to 189,144 shares valued at $29.63 million. Other institutional investors also adjusted their positions in the CRM provider, which has an …

Quantinno Capital Management LP Purchases 34,352 Shares of Kforce Inc. $KFRC

Quantinno Capital Management LP significantly increased its stake in Kforce Inc. by 88.6% in the first quarter, acquiring an additional 34,352 shares, bringing its total to 73,135 shares valued at $2.14 million. Kforce, a professional staffing services firm, has shown strong financial performance, exceeding …

Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside

The average 12-month price target for Orchestra BioMed Holdings, Inc. (OBIO) stock has increased to $12.33, up from $12.17, according to estimates from six analysts. This new target suggests a potential upside of approximately 177% from its closing price on August 10. The consensus …

Kforce rated BUY for 12 months but advised to buy only on price dips, not at current highs.

Kforce (KFRC) has received a "BUY" rating for the next 12 months due to strong Q1 revenue growth and increased guidance, anticipating 20% EPS growth. However, analysts recommend purchasing shares only on price retracements in the $40–44 range, as the current valuation is considered …

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed announced its second-quarter 2026 financial results, highlighting progress in its two cardiovascular programs: AVIM Therapy and Virtue SAB. The company reported that its BACKBEAT trial for AVIM Therapy is on track to meet its target enrollment by Q3 2026, with primary data …

Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital

Orchestra BioMed Holdings reported a net loss of $24.1 million in Q2 2026, widening from the previous year, despite an 89% drop in revenue to $88,000. The loss was primarily due to increased research and development expenses for pivotal clinical trials. However, the company …

Why the Market Dipped But Oracle (ORCL) Gained Today

In the latest trading session, Oracle (ORCL) closed at $151.05, marking a +2.74% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.06%. At the same time, the Dow lost 0.11%, and the tech-heavy Nasdaq lost …

Dorchester Minerals: Cheap Royalty Play Despite Oil Price Headwinds (NASDAQ:DMLP)

Salesforce Inc. stock outperforms competitors on strong trading day

Shares of Salesforce Inc. (CRM) rose 2.47% to $197.51, outperforming the broader market during a poor trading session where the S&P 500 Index and Dow Jones Industrial Average both saw slight declines. This marks the stock's second consecutive day of gains.

Orchestra BioMed Reports Q2 2026 Results and Updates Progress on BACKBEAT and Virtue Pivotal Trials

Orchestra BioMed reported its Q2 2026 financial results, including a net loss of $24.1 million, and provided updates on its pivotal clinical trials. The BACKBEAT Trial for uncontrolled hypertension is on track to enroll 284 patients by Q3 2026, with primary results expected in …

Orchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend